Page last updated: 2024-11-05

terbacil

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Terbacil is a synthetic uracil derivative herbicide that inhibits photosynthesis in plants. It is primarily used to control weeds in various crops, including alfalfa, clover, and grasses. Its mode of action involves interfering with the synthesis of chlorophyll, a key pigment in photosynthesis. Terbacil has been extensively studied for its efficacy as a herbicide and its potential environmental impact. Research on terbacil has focused on understanding its absorption, translocation, and degradation in plants and soil, as well as its impact on non-target organisms. Terbacil is also under investigation for its potential use in controlling invasive plant species.'

terbacil: RN given refers to parent cpd; structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID22188
CHEMBL ID1901822
CHEBI ID9447
SCHEMBL ID53799
SCHEMBL ID23302272
MeSH IDM0057613

Synonyms (66)

Synonym
2,4(1h,3h)-pyrimidinedione, 5-chloro-3-(1,1-dimethylethyl)-6-methyl-
uracil, 3-tert-butyl-5-chloro-6-methyl-
CHEMDIV2_000511
5902-51-2
terbacil
NCGC00163865-02
NCGC00163865-01
experimental herbicide 732
sinbar
turbacil
caswell no. 821a
du pont 732
hsdb 1418
epa pesticide chemical code 012701
geonter
5-chloro-3-(1,1-dimethylethyl)-6-methyl-2,4(1h,3h)-pyrimidinedione
brn 0643054
einecs 227-595-1
terbacil [ansi:bsi:iso]
3-t-butyl-5-chloro-6-methyluracil
compound 732
5-chloro-3-tert-butyl-6-methyluracil
3-tert.butyl-5-chlor-6-methyluracil [german]
du pont herbicide 732
3-tert-butyl-5-chloro-6-methyluracil
3-tert-butyl-5-chloro-6-methylpyrimidine-2,4(1h,3h)-dione
NCGC00163865-03
HMS1370H05
3-tert-butyl-5-chloro-6-methyl-1h-pyrimidine-2,4-dione
STK874197
AKOS001022252
NCGC00163865-04
NCGC00163865-05
3-tert-butyl-5-chloro-6-methyl-1,2,3,4-tetrahydropyrimidine-2,4-dione
tox21_201244
tox21_300831
NCGC00258796-01
cas-5902-51-2
NCGC00254735-01
dtxsid8024317 ,
dtxcid104317
unii-s0017j6e25
3-tert.butyl-5-chlor-6-methyluracil
s0017j6e25 ,
5-24-07-00036 (beilstein handbook reference)
terbacil [mi]
terbacil [iso]
terbacil [hsdb]
SCHEMBL53799
CHEBI:9447 ,
3-tert-butyl-5-chloro-6-methyl-2,4(1h,3h)-pyrimidinedione #
sinbar 80w (salt/mix)
dpx-d732
herbicide 732
5-chloro-3-(1,1-dimethylethyl)-6-methyl-pyrimidinedione
CHEMBL1901822
SR-01000445711-1
sr-01000445711
terbacil, pestanal(r), analytical standard
Z56754343
terbacil 10 microg/ml in isooctane
3-(tert-butyl)-5-chloro-6-methylpyrimidine-2,4(1h,3h)-dione
Q2404316
SCHEMBL23302272
EN300-16676
CS-0236047

Research Excerpts

[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (2)

ClassDescription
organohalogen compoundA compound containing at least one carbon-halogen bond (where X is a halogen atom).
pyrimidinesAny compound having a pyrimidine as part of its structure.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (7)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
nuclear receptor subfamily 1, group I, member 3Homo sapiens (human)Potency69.21790.001022.650876.6163AID1224838
glucocorticoid receptor [Homo sapiens]Homo sapiens (human)Potency35.48130.000214.376460.0339AID588532
estrogen-related nuclear receptor alphaHomo sapiens (human)Potency17.38670.001530.607315,848.9004AID1224841
peroxisome proliferator activated receptor gammaHomo sapiens (human)Potency22.07860.001019.414170.9645AID743191
thyroid hormone receptor beta isoform aHomo sapiens (human)Potency0.00790.010039.53711,122.0200AID588545
nuclear factor erythroid 2-related factor 2 isoform 1Homo sapiens (human)Potency44.49820.000627.21521,122.0200AID651741; AID743219
DNA polymerase kappa isoform 1Homo sapiens (human)Potency18.88760.031622.3146100.0000AID588579
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (13)

TimeframeStudies, This Drug (%)All Drugs %
pre-19904 (30.77)18.7374
1990's6 (46.15)18.2507
2000's2 (15.38)29.6817
2010's1 (7.69)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 31.16

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index31.16 (24.57)
Research Supply Index2.64 (2.92)
Research Growth Index4.34 (4.65)
Search Engine Demand Index42.49 (26.88)
Search Engine Supply Index2.50 (0.95)

This Compound (31.16)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other13 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]